Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Overall Market Size
2.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size: 2021 VS 2028
2.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Paroxysmal Nocturnal Hemoglobinuria Treatment Players in Global Market
3.2 Top Global Paroxysmal Nocturnal Hemoglobinuria Treatment Companies Ranked by Revenue
3.3 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Companies
3.4 Top 3 and Top 5 Paroxysmal Nocturnal Hemoglobinuria Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Paroxysmal Nocturnal Hemoglobinuria Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Paroxysmal Nocturnal Hemoglobinuria Treatment Players in Global Market
3.6.1 List of Global Tier 1 Paroxysmal Nocturnal Hemoglobinuria Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Paroxysmal Nocturnal Hemoglobinuria Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size Markets, 2021 & 2028
4.1.2 ACH-4471
4.1.3 ALN-CC5
4.1.4 ALXN-1210
4.1.5 AMY-101
4.1.6 APL-2
4.1.7 Others
4.2 By Type - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue & Forecasts
4.2.1 By Type - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2017-2022
4.2.2 By Type - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2023-2028
4.2.3 By Type - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue & Forecasts
5.2.1 By Application - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2017-2022
5.2.2 By Application - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2023-2028
5.2.3 By Application - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2021 & 2028
6.2 By Region - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue & Forecasts
6.2.1 By Region - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2017-2022
6.2.2 By Region - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2023-2028
6.2.3 By Region - Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2017-2028
6.3.2 US Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.3.3 Canada Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.3.4 Mexico Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2017-2028
6.4.2 Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.4.3 France Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.4.4 U.K. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.4.5 Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.4.6 Russia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.4.8 Benelux Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2017-2028
6.5.2 China Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.5.3 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.5.4 South Korea Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.5.6 India Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2017-2028
6.6.2 Brazil Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.6.3 Argentina Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue, 2017-2028
6.7.2 Turkey Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.7.3 Israel Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
6.7.5 UAE Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Achillion Pharmaceuticals Inc
7.1.1 Achillion Pharmaceuticals Inc Corporate Summary
7.1.2 Achillion Pharmaceuticals Inc Business Overview
7.1.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.1.4 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.1.5 Achillion Pharmaceuticals Inc Key News
7.2 Akari Therapeutics Plc
7.2.1 Akari Therapeutics Plc Corporate Summary
7.2.2 Akari Therapeutics Plc Business Overview
7.2.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.2.4 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.2.5 Akari Therapeutics Plc Key News
7.3 Alexion Pharmaceuticals Inc
7.3.1 Alexion Pharmaceuticals Inc Corporate Summary
7.3.2 Alexion Pharmaceuticals Inc Business Overview
7.3.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.3.4 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.3.5 Alexion Pharmaceuticals Inc Key News
7.4 Alnylam Pharmaceuticals Inc
7.4.1 Alnylam Pharmaceuticals Inc Corporate Summary
7.4.2 Alnylam Pharmaceuticals Inc Business Overview
7.4.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.4.4 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.4.5 Alnylam Pharmaceuticals Inc Key News
7.5 Amgen Inc
7.5.1 Amgen Inc Corporate Summary
7.5.2 Amgen Inc Business Overview
7.5.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.5.4 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.5.5 Amgen Inc Key News
7.6 Apellis Pharmaceuticals Inc
7.6.1 Apellis Pharmaceuticals Inc Corporate Summary
7.6.2 Apellis Pharmaceuticals Inc Business Overview
7.6.3 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.6.4 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.6.5 Apellis Pharmaceuticals Inc Key News
7.7 F. Hoffmann-La Roche Ltd
7.7.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.7.2 F. Hoffmann-La Roche Ltd Business Overview
7.7.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.7.4 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.7.5 F. Hoffmann-La Roche Ltd Key News
7.8 ISU ABXIS Co Ltd
7.8.1 ISU ABXIS Co Ltd Corporate Summary
7.8.2 ISU ABXIS Co Ltd Business Overview
7.8.3 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.8.4 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.8.5 ISU ABXIS Co Ltd Key News
7.9 Novartis AG
7.9.1 Novartis AG Corporate Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.9.4 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.9.5 Novartis AG Key News
7.10 NovelMed Therapeutics Inc
7.10.1 NovelMed Therapeutics Inc Corporate Summary
7.10.2 NovelMed Therapeutics Inc Business Overview
7.10.3 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.10.4 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.10.5 NovelMed Therapeutics Inc Key News
7.11 Omeros Corp
7.11.1 Omeros Corp Corporate Summary
7.11.2 Omeros Corp Business Overview
7.11.3 Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.11.4 Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.11.5 Omeros Corp Key News
7.12 Ra Pharmaceuticals Inc
7.12.1 Ra Pharmaceuticals Inc Corporate Summary
7.12.2 Ra Pharmaceuticals Inc Business Overview
7.12.3 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.12.4 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.12.5 Ra Pharmaceuticals Inc Key News
7.13 Regeneron Pharmaceuticals Inc
7.13.1 Regeneron Pharmaceuticals Inc Corporate Summary
7.13.2 Regeneron Pharmaceuticals Inc Business Overview
7.13.3 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.13.4 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.13.5 Regeneron Pharmaceuticals Inc Key News
7.14 Regenesance BV
7.14.1 Regenesance BV Corporate Summary
7.14.2 Regenesance BV Business Overview
7.14.3 Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Major Product Offerings
7.14.4 Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue in Global Market (2017-2022)
7.14.5 Regenesance BV Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer